EXL — Elixinol Wellness Share Price
0.000.00%
Last trade - 00:00- AU$6.18m
- AU$7.06m
- AU$14.99m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.62 | ||
| Price to Tang. Book | 1.61 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.41 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -40.46% | ||
| Return on Equity | -20.89% | ||
| Operating Margin | -36.35% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 15.11 | 9.38 | 7.08 | 8.48 | 14.99 | n/a | n/a | -13.68% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Elixinol Wellness Limited is an Australia-based hemp company. The Company is engaged in marketing and selling hemp derived and other plant-based nutraceuticals, skincare and food products. In Australia, it operates a vertically integrated business, which produces, manufactures, and distributes a range of complementary products delivered across four verticals: human nutrition, human wellness, pet wellness and superfood ingredients. These products are sold under brands including Hemp Foods Australia, Mt Elephant and Field Day and are sold through grocery, wholesale, and e-commerce channels. In the Americas, it is engaged in marketing and selling quality Elixinol branded hemp and other plant-derived nutraceutical and skincare products based in Colorado, United States. In the United Kingdom, Japan, Brazil, Mexico and South Africa, branded hemp and other plant-derived products are available to consumers via exclusive distribution and/or trademark and know-how licensing agreements.
Directors
- Helen Wiseman NEC
- Oliver Horn CEO (48)
- Ron Dufficy CFO
- Ali Atcha CEX
- Leif Harrison CEX
- Gabriel Ettenson CTO
- Greg Smith CIO
- Teresa Cleary GCN
- Linda McLeod MDR
- Paul Benhaim NED
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 4th, 2017
- Public Since
- January 8th, 2018
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 220,820,137
- Address
- World Square, Sydney, 2002
- Web
- https://www.elixinolwellness.com/site/content/
- Phone
- +61 240444585
- Auditors
- BDO Audit Pty Ltd
Upcoming Events for EXL
Elixinol Wellness Ltd Annual Shareholders Meeting
Half Year 2025 Elixinol Wellness Ltd Earnings Release
Similar to EXL
Accent
Australian Stock Exchange - SEATS
Adairs
Australian Stock Exchange - SEATS
Autosports
Australian Stock Exchange - SEATS
Baby Bunting
Australian Stock Exchange - SEATS
Beacon Lighting
Australian Stock Exchange - SEATS
FAQ
What is the Elixinol Wellness share price?
As of Today at 02:24 UTC, shares in Elixinol Wellness are trading at AU$0.03. This share price information is delayed by 15 minutes.
How has the Elixinol Wellness share price performed this year?
Shares in Elixinol Wellness last closed at AU$0.03 and the price had moved by -22.22% over the past 365 days. In terms of relative price strength the Elixinol Wellness share price has underperformed the ASX All Ordinaries Index by -25.44% over the past year.
What are the analyst and broker recommendations for Elixinol Wellness?
The overall consensus recommendation for Elixinol Wellness is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Elixinol Wellness dividend yield?
Elixinol Wellness does not currently pay a dividend.
Does Elixinol Wellness pay a dividend?
Elixinol Wellness does not currently pay a dividend.
When does Elixinol Wellness next pay dividends?
Elixinol Wellness does not currently pay a dividend.
How do I buy Elixinol Wellness shares?
To buy shares in Elixinol Wellness you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Elixinol Wellness?
As of the previous close price of AU$0.03, shares in Elixinol Wellness had a market capitalisation of AU$6.18m.
Where are Elixinol Wellness shares listed?
Here are the trading details for Elixinol Wellness:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: EXL
What kind of share is Elixinol Wellness?
Based on an overall assessment of its quality, value and momentum Elixinol Wellness is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Elixinol Wellness share price forecast for 2025?
The analyst consensus target price for shares in Elixinol Wellness is AU$0.03. That is 14.29% above the last closing price of AU$0.03.
Analysts covering Elixinol Wellness currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Elixinol Wellness share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Elixinol Wellness. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -9.26%.
As of the last closing price of AU$0.03, shares in Elixinol Wellness were trading -16.5% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Elixinol Wellness PE Ratio?
The Elixinol Wellness PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Elixinol Wellness?
Elixinol Wellness' management team is headed by:
- Helen Wiseman - NEC
- Oliver Horn - CEO
- Ron Dufficy - CFO
- Ali Atcha - CEX
- Leif Harrison - CEX
- Gabriel Ettenson - CTO
- Greg Smith - CIO
- Teresa Cleary - GCN
- Linda McLeod - MDR
- Paul Benhaim - NED